Boston Scientific Announces Conference Call Discussing Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- CoreWeave stock drops on dilution fears and debt concerns
- SpaceX to acquire Grain Management's 800 MHz spectrum portfolio
- Oracle and these 6 stocks are newest addition to Mizuho Top Picks list
- Anthropic launches cyber defense program for infrastructure and open-source
- Devon Energy to sell Eagle Ford assets to Crescent Energy for $4.2B
Boston Scientific (BSX) PT Raised to $48 at Morgan Stanley Following Healthcare Conference
October 2, 2018 7:31 AM EDTMorgan Stanley analyst David Lewis raised the price target on Boston Scientific (NYSE: BSX) to $48.00 (from $38.00) while maintaining a Overweight rating following the Morgan Stanley Healthcare Conference. Investors were concerned 9 deals for $1.6bn year-to-date suggested a weakening core business, but Lewis believes the... More



